Pakistan is set to launch joint insulin production with Russia in a bid to curb reliance on costly imports and expand access to essential medicines, Special Assistant to the Prime Minister on Industries and Production Haroon Akhtar Khan said after chairing a high-level meeting with the Drug Regulatory Authority of Pakistan (DRAP) and Russian officials…
Citi Pharma has become Pakistan’s largest antibiotics maker after a China-backed expansion that lifted output tenfold to 100,000 vials a day.
Tariffs on India, deregulation boost industry; Citi Pharma eyes American expansion Pakistan’s pharmaceutical exports surged 34% to an all-time high of $457 million in fiscal year 2025, and analysts say U.S. tariffs on Indian competitors could open the door for even stronger growth ahead. The milestone, up from $341 million in FY24 and $328 million…
